Related Experiment Video
Updated: Aug 4, 2026

Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
Microbes and Alzheimer' disease: lessons from H. pylori and GUT microbiota
F Franceschi1, V Ojetti, M Candelli
1Emergency Medicine, Internal Medicine and Gastroenterology, and Institute of Neurology; Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy. veronica.ojetti@gmail.com.
Objective:
the role of microbes and chronic inflammation in the pathogenesis of Alzheimer' disease (AD) has been postulated by many authors. On the other hand, several studies have reported the main role of H. pylori infection and/or GUT microbiota alteration in promoting chronic inflammation, thus possibly influencing both occurrence and evolution of AD. In this article, we analyze the most important and recent studies performed on this field both on humans and animals and provide possible pathogenic explanations.
Results:
all main and most recent animal, human, epidemiological and in-silico studies, showed a role of H. pylori and/or dysbiosis in AD, mostly through the promotion of systemic chronic inflammation and/or by triggering molecular mimicry mechanisms. In particular, H. pylori infection seems to be related to a poorer cognitive performance.
Conclusions:
Indeed, bacteria have been shown to affect neurodegeneration by promoting inflammation, inducing molecular mimicry mechanisms and accumulation of Aβ into the brain. These findings open the way for H. pylori eradicating trials and/or GUT microbiota remodulating strategies. Therefore, further studies are now needed in order to test whether antibiotics, pre and/or probiotics may exert a beneficial effect in the prevention of AD.
Insights
Helicobacter pylori (H. pylori) infection and gut dysbiosis may contribute to Alzheimer's disease (AD) pathogenesis by promoting chronic inflammation and molecular mimicry. Further research into H. pylori eradication and gut microbiota modulation is warranted for AD prevention.
Area of Science:
- Neuroscience
- Microbiology
- Immunology
Background:
- The role of microbes and chronic inflammation in Alzheimer's disease (AD) pathogenesis is increasingly recognized.
- Helicobacter pylori (H. pylori) infection and gut microbiota alterations are implicated in chronic inflammation, potentially influencing AD.
- Existing literature suggests a link between these factors and neurodegenerative processes.
Purpose of the Study:
- To analyze recent studies on the role of H. pylori and gut dysbiosis in Alzheimer's disease.
- To explore potential pathogenic mechanisms linking microbial factors to AD.
- To provide a comprehensive overview of current research in this field.
Main Methods:
- Review and analysis of recent animal, human, epidemiological, and in-silico studies.
- Examination of pathogenic explanations for the observed associations.
- Synthesis of evidence regarding microbial influence on neurodegeneration.
Main Results:
- Multiple studies indicate a role for H. pylori and/or gut dysbiosis in AD pathogenesis.
- These effects are primarily mediated through the promotion of systemic chronic inflammation and molecular mimicry.
- H. pylori infection is specifically associated with poorer cognitive performance in individuals with AD.
Conclusions:
- Bacterial involvement in neurodegeneration is supported by evidence of inflammation, molecular mimicry, and amyloid-beta (Aβ) accumulation.
- Findings suggest potential therapeutic strategies involving H. pylori eradication and gut microbiota modulation.
- Further clinical trials are needed to evaluate the efficacy of antibiotics, prebiotics, and probiotics in AD prevention.
Related Concept Videos
Introduction to the Human Microbiota
Microbiota of the Stomach and Small Intestine
Gut-Brain Axis
Microbiota Modulation by Antibiotics
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology

